Tag : ALPHA-FETOPROTEIN

CONFERENCE UPDATE

Multi-target blood test improves early detection of HCC: Evidence from the ALTUS prospective study
The prospective ALTUS study found that a multi-target HCC blood test (mt-HBT) outperformed ultrasound in detecting early- and very early-stage hepatocellular carcinoma (HCC). By providing operator-independent and scalable surveillance, mt-HBT offers a promising alternative to imaging, with the potential to enhance early detection, adherence, and clinical outcomes in at-risk patients.